Literature DB >> 8661816

Pulmonary and thymic carcinoid tumors.

M E Dusmet1, M F McKneally.   

Abstract

Carcinoid tumors of the lung and bronchi are usually benign lesions with no influence on life expectancy, although occasionally, they are malignant with a poor prognosis. Between these two extremes are atypical carcinoids, which can be slow-growing tumors with an average 5-year survival of 60% and an average 10-year survival of 40%. The myriad names used to describe these lesions complicates the understanding of their behavior, especially as the term carcinoid is used to describe the complete spectrum of disease or exclusively the benign well differentiated lesions with an excellent prognosis. Thymic carcinoids are uncommon lesions. Their prognosis is poor, even in cases that appear favorable in terms of resectability and histology. Pulmonary carcinoids present uncommonly with a paraneoplasic syndrome. Both carcinoid and Cushing syndromes are seen with approximately 2% of these lesions. Cushing syndrome can be present in as many as one-third of patients with thymic carcinoids but an association with the carcinoid syndrome has never been described.

Entities:  

Mesh:

Year:  1996        PMID: 8661816     DOI: 10.1007/s002689900029

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

Review 1.  Neuroendocrine tumors of the thymus.

Authors:  Pier Luigi Filosso; Enrico Ruffini; Paolo Solidoro; Matteo Roffinella; Paolo Olivo Lausi; Paraskevas Lyberis; Alberto Oliaro; Francesco Guerrera
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  Advances in the treatment of neuroendocrine tumors.

Authors:  Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2005-09

3.  Endobronchial carcinoid in a child: depiction with three-dimensional volume rendering.

Authors:  Gregory F Connor; Elliott K Fishman
Journal:  Pediatr Radiol       Date:  2004-09-04

Review 4.  Imaging in covert ectopic ACTH secretion: a CT pictorial review.

Authors:  Paul A Sookur; Anju Sahdev; Andrea G Rockall; Andrea M Isidori; John P Monson; Ashley B Grossman; Rodney H Reznek
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

5.  Ten-year Single Center Experience of Pulmonary Carcinoid Tumors and Diagnostic Yield of Bronchoscopic Biopsy.

Authors:  Renee K Dixon; Edward James Britt; Giora A Netzer; Majid Afshar; Allen Burke; Sandy Liu; Jeudy Jean; Nirav G Shah
Journal:  Lung       Date:  2016-08-20       Impact factor: 2.584

6.  Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction.

Authors:  Diamantis I Tsilimigras; Demetrios Moris; Ioannis Ntanasis-Stathopoulos; Davide Patrini; Nikolaos Panagiotopoulos
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

7.  CT/MRI of neuroendocrine tumours.

Authors:  Rodney H Reznek
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

8.  Atypical or typical adrenocorticotropic hormone-producing pulmonary carcinoids and the usefulness of 11C-5-hydroxytryptophan positron emission tomography: two case reports.

Authors:  Jeanette Wahlberg; Bertil Ekman
Journal:  J Med Case Rep       Date:  2013-03-19

9.  Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: A propensity-matched study based on the SEER database.

Authors:  Junmiao Wen; Jiayan Chen; Donglai Chen; Di Liu; Xinyan Xu; Lv Huang; Jianzhao Cao; Junhua Zhang; Yu Gu; Min Fan; Yongbing Chen
Journal:  Thorac Cancer       Date:  2018-10-01       Impact factor: 3.500

10.  Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic.

Authors:  Stephanie H Chang; Michael Zervos; Amie Kent; Abraham Chachoua; Costas Bizekis; Harvey Pass; Robert J Cerfolio
Journal:  Eur J Cardiothorac Surg       Date:  2020-12-01       Impact factor: 4.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.